⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL88030 | 0.82 | — | — | |
| Glycerin SCHEMBL6037524 | 0.80 | LMNA (0.45) | — | |
| SCHEMBL5374083 | 0.79 | LMNA (0.42) | — | |
| SCHEMBL11392903 | 0.79 | — | — | |
| SCHEMBL5558849 | 0.75 | — | — | |
| SCHEMBL28472492 | 0.72 | — | — | |
| SCHEMBL30631090 | 0.71 | ALDH1A1 (0.35) | — | |
| SCHEMBL699548 | 0.69 | — | — | |
| SCHEMBL3673695 | 0.67 | — | — | |
| SCHEMBL27390028 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3072503-B1 | OPHTHALMIC COMPOSITION FOR THE CORNEAL PROTECTION | DMG ITALIA SRL (IT) | 2020-09-23 | — | — | EP | claimed |
| WO-2015108355-A1 | GLYCERYL PHOSPHORYL CHOLINE CRYSTAL AND PREPARATION METHOD THEREFOR | 지준홍 | 2015-07-23 | — | — | WO | claimed |
| CN-110452262-A | The synthetic method of platelet activating factor (PAF) analog | AMTECH BIOENGINEERING LTD INC | 2019-11-15 | — | — | CN | disclosed |
| CN-102421431-B | Haemodialysis and peritoneal dialysis solution comprising one or more creatine compounds | 克雷勒内有限公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-107303278-A | A kind of solid dispersions of HC 1119 and preparation method thereof | 成都海创药业有限公司 | 2017-10-31 | — | — | CN | disclosed |
| CN-104136626-B | N-TERMINALLY MODIFIED OLIGOPEPTIDES AND USES THEREO | 诺沃—诺迪斯克有限公司 | 2017-05-03 | — | — | CN | disclosed |
| CN-102858437-B | For the substrate and preparation method thereof of fixed function material | TEMASEK POLYTECHNIC (SG) | 2016-02-10 | — | — | CN | disclosed |
| WO-2015108355-A1 | GLYCERYL PHOSPHORYL CHOLINE CRYSTAL AND PREPARATION METHOD THEREFOR | 지준홍 | 2015-07-23 | — | — | WO | disclosed |
| CN-102858437-A | A substrate for immobilizing functional substances and method for preparing the same | TEMASEK POLYTECHNIC | 2013-01-02 | — | — | CN | disclosed |
| US-8202512-B2 | Metabolic uncoupling therapy | MCCLEARY EDWARD LARRY (US) | 2012-06-19 | — | — | US | disclosed |
| CN-1956780-B | Affinity particles and affinity separation method | SHISEIDO CO LTD | 2011-03-23 | — | — | CN | disclosed |
| US-20070160590-A1 | Metabolic uncoupling therapy | MCCLEARY EDWARD L | 2007-07-12 | — | — | US | disclosed |
| CN-1956780-A | Affinity particles and affinity separation method | SHISEIDO CO LTD (JP) | 2007-05-02 | — | — | CN | disclosed |
| CN-1276255-C | Renal disease detection reagent and method for detecting renal disease and components thereof | INT REAGENTS CORP (JP) | 2006-09-20 | — | — | CN | disclosed |
| US-20050002992-A1 | Foods, beverages, condiments, spices and salad dressings with specialized supplements | MCCLEARY EDWARD LARRY (US) | 2005-01-06 | — | — | US | disclosed |
| CN-1441904-A | Means of examining nephropathy | INT REAGENTS CORP (JP) | 2003-09-10 | — | — | CN | disclosed |
| CN-1097458-C | Stable oil-in-water emulsions incorporating taxine (taxol) and method of making same | HEMAGEN PFC (US) | 2003-01-01 | — | — | CN | disclosed |
| CN-1153474-A | Stable oil-in-water emulsions incorporating taxine (taxol) and method of making same | HEMAGEN PFC (US) | 1997-07-02 | — | — | CN | disclosed |
| CN-1072593-A | The surfactant and the using method that contain alkyl phosphorylcholine or alkyl glycerol Phosphorylcholine | HEMAGEN PFC (US) | 1993-06-02 | — | — | CN | disclosed |
| EP-0496474-A2 | Saline derivates of glyceryl phosphoryl myoinositol having therapeutical activity, their preparation and pharmaceutical compositions containing them. | GOLGI S.A. (CH) | 1992-07-29 | — | — | EP | disclosed |